However, PYY does not seem to exert an acute impact on glucose-stimulated insulin secretion [27], the insulinotropic action of GIP is impaired in T2D [24], and GLP1 responses tended to be higher in the MCT + WPI treatment when only the 18 completers were considered in this study. The gene discussed is GIP; the disease is type 2 diabetes mellitus.